Squarepoint’s TScan Therapeutics TCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.6K Buy
+22,497
New +$32.6K ﹤0.01% 2645
2025
Q1
Sell
-19,461
Closed -$59.2K 3205
2024
Q4
$59.2K Buy
+19,461
New +$59.2K ﹤0.01% 2618
2024
Q3
Sell
-19,290
Closed -$113K 3030
2024
Q2
$113K Buy
+19,290
New +$113K ﹤0.01% 2244